Strumento inattivo

Altre lingue Gentian Diagnostics AS Oslo Bors

Azioni

NO0010748866

Tempo reale stimato Cboe Europe Altri mercati azionari 14:32:19 21/06/2024			Variaz. 5gg	Var. 1 gen.
42,7 ^NOK	-28,24%		-3,25%	+9,17%

30/04	Gentian Diagnostics ASA riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
30/04	Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Gentian Diagnostics : Production assistant - HQ based in Moss, Norway	13/05
Gentian Diagnostics : Application Sales Specialist (US based)	13/05
Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
Gentian Diagnostics : 30 April 2024 - Quarterly Presentation - Q1 2024	30/04
Gentian Diagnostics : 30 April 2024 - Quarterly Report - Q1 2024	30/04
Gentian Diagnostics Asa Resolves to Elect Ms. Hilja Ibert as Chairperson of the Board of Directors	29/04
Gentian Diagnostics ASA Appoints Mr. Njaal Kind as Acting CEO	29/04
Gentian Diagnostics: New acting CEO and Chairperson of the Board of Directors	29/04
Gentian Diagnostics : Scientists to Gentian’s R&D department	08/04
Gentian Diagnostics ASA Announces Resignation of Hilja Ibert as CEO, Effective on April 29, 2024	21/03
Tomas Settevik Not to Stand for Re-Election as Chairperson of Gentian Diagnostics ASA, Effective April 29, 2024	21/03
Gentian Diagnostics' CEO Resigns, Wins Recommendation to Succeed Chair	21/03
Gentian Diagnostics ASA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	09/02
Gentian Diagnostics Asa Announces Resignation of Frank Frantzen from the Board of Directors	18/12
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference	14/12
Gentian Diagnostics ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/10/23
Gentian Diagnostics : Sales and Application Specialist - Nordic	10/10/23
Gentian Diagnostics ASA Expands Product Portfolio With Turbidimetric Retinol-Binding Protein Immunoassay	29/09/23
Gentian Diagnostics ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23
Gentian Diagnostics ASA (OB:GENT) acquired Getica Ab from Erling Sundrehagen for SEK 2.8 million.	03/07/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Gentian Diagnostics AS Oslo Bors

Azioni

NO0010748866

Altre lingue

Filtri